Medovate has concluded a distribution agreement with Fannin Limited giving the Dublin-based company distribution rights for SAFIRA (SAFer Injection for Regional Anaesthesia) across the Island of Ireland.
The SAFIRA system has been developed by Medovate in collaboration with anaesthetists in the UK National Health Service (NHS) and has been designed to help revolutionise standard regional anaesthesia clinical practice and promote patient safety. Regional anaesthesia is a widely used anaesthetic practice to place peripheral nerve blocks to numb a specific part of the body prior to a surgical procedure so the patient remains awake but feels nothing.
With the appointment of Fannin as a further distributor for the SAFIRA technology, anaesthetists across the Island of Ireland will be able to access and apply the SAFIRA system in their everyday practice and realise the benefits of the technology for both them and their patients.
Kieran O’Halloran, commercial director Fannin said: ”Fannin is delighted to have partnered with Medovate to become the exclusive distributor across the island of Ireland for the SAFIRA (SAFer Injection for Regional Anaesthesia) system.”
